Does BRIGATINIB Cause Neoplasm progression? 172 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 172 reports of Neoplasm progression have been filed in association with BRIGATINIB (Alunbrig). This represents 5.2% of all adverse event reports for BRIGATINIB.
172
Reports of Neoplasm progression with BRIGATINIB
5.2%
of all BRIGATINIB reports
32
Deaths
24
Hospitalizations
How Dangerous Is Neoplasm progression From BRIGATINIB?
Of the 172 reports, 32 (18.6%) resulted in death, 24 (14.0%) required hospitalization, and 1 (0.6%) were considered life-threatening.
Is Neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BRIGATINIB. However, 172 reports have been filed with the FAERS database.
What Other Side Effects Does BRIGATINIB Cause?
Death (405)
Non-small cell lung cancer (370)
Off label use (256)
Diarrhoea (239)
Metastases to central nervous system (219)
Nausea (218)
Lung neoplasm malignant (216)
Fatigue (201)
Blood creatine phosphokinase increased (198)
Product dose omission issue (193)
What Other Drugs Cause Neoplasm progression?
PALBOCICLIB (10,885)
SUNITINIB MALATE (1,920)
CYCLOPHOSPHAMIDE (1,588)
CARBOPLATIN (1,370)
AXITINIB (1,315)
DOXORUBICIN (1,276)
LETROZOLE (1,225)
PACLITAXEL (1,180)
CRIZOTINIB (1,161)
VINCRISTINE (1,106)
Which BRIGATINIB Alternatives Have Lower Neoplasm progression Risk?
BRIGATINIB vs BRILINTA
BRIGATINIB vs BRILIQUE
BRIGATINIB vs BRIMONIDINE
BRIGATINIB vs BRIMONIDINE\BRINZOLAMIDE
BRIGATINIB vs BRIMONIDINE\TIMOLOL